Accelerated Pharma (Accelerated Pharma) Dividend Yield % : 0.00% (As of May. 16, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Dividend Yield %?

As of today (2024-05-16), the Trailing Annual Dividend Yield of Accelerated Pharma is 0.00%.

The historical rank and industry rank for Accelerated Pharma's Dividend Yield % or its related term are showing as below:

ACCP's Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.67
* Ranked among companies with meaningful Dividend Yield % only.

Accelerated Pharma's Dividend Payout Ratio for the three months ended in Mar. 2017 was 0.00.

As of today (2024-05-16), the Forward Dividend Yield % of Accelerated Pharma is 0.00%.

Accelerated Pharma's Dividends per Share for the three months ended in Mar. 2017 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Accelerated Pharma Dividend Yield % Historical Data

The historical data trend for Accelerated Pharma's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Dividend Yield % Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dividend Yield %

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Dividend Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Accelerated Pharma's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerated Pharma's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Dividend Yield % falls into.

Accelerated Pharma Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Accelerated Pharma (NAS:ACCP) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Accelerated Pharma Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines